#Contrast and Imaging Agents in Interventional X-ray Research Report

[deshpandeisha]

Overview of Angiography Equipment: Types and Uses

The Angiography Equipment market is a growing industry that is witnessing increasing demand for its applications in the diagnosis and treatment of cardiovascular diseases. Angiography is a medical imaging technique that uses X-rays and contrast agents to visualize the blood vessels in the body. The equipment used for angiography includes X-ray machines, catheters, and contrast agents, which are used to produce detailed images of the blood vessels.

The global angiography equipment market size is expected to reach USD 20.32 Billion in 2032, and register a revenue CAGR of 5.0% during the forecast period, according to latest analysis by Emergen Research. One of the major drivers of the Angiography Equipment market is the increasing prevalence of cardiovascular diseases. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, with an estimated 17.9 million deaths each year. As a result, there is a growing demand for medical devices and equipment, including angiography equipment, to diagnose and treat these diseases.

Another driver of the Angiography Equipment market is the technological advancements in the equipment. The development of digital angiography systems has improved the accuracy and efficiency of the diagnosis and treatment of cardiovascular diseases. Furthermore, the use of minimally invasive procedures, such as percutaneous coronary intervention (PCI), has increased the demand for angiography equipment, as it allows for safer and more precise procedures.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/1892

Competitive Terrain:

The global Angiography Equipment industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

GE HealthCare, Siemens, Koninklijke Philips N.V., Shimadzu Corporation, Terumo Corporation, Abbott, Boston Scientific Corporation, Medtronic, CANON MEDICAL SYSTEMS USA, INC., Cordis

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Angiography Equipment market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Angiography Equipment market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Angiography Equipment market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/1892

Market Segmentations of the Angiography Equipment Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Angiography Equipment market on the basis of product, application, and region:

Segments Covered in this report are:

Product Outlook (Revenue, USD Billion; 2019–2032)

Angiography Systems

Angiography Catheters

Angiography Contrast Media

Vascular Closure Devices (VCDs)

Angiography Balloons

Angiography Guidewires

Angiography Accessories

Technology Outlook (Revenue, USD Billion; 2019–2032)

X-Ray Angiography

Image Intensifiers

Flat-panel Detectors

CT Angiography

MR Angiography

Others

Procedure Outlook (Revenue, USD Billion; 2019–2032)

Coronary Angiography

Endovascular Angiography

Neuroangiography

Onco-Angiography

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/angiography-equipment-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1892

[kiransharma123]

Global Contrast and Imaging Agents in Interventional X-ray Market – Industry Trends and Forecast to 2026

Contrast and imaging agents in Interventional X-ray Market plays an important role in improving the health-related issues in the healthcare sector. Contrast material, which is also known as contrast agents or contrast media, is used to improve image quality produced by X-rays, computed tomography (CT) and other imaging techniques. By using contrast materials radiologists can distinguish normal from abnormal conditions within the body.

Contrast agents or media doesn’t permanently discolour internal organs. Prior to the imaging exam, when the contrast agent is introduced in the body, these contrast materials forms some shape in the body which helps to appear different than that if no contrast agent is administered. Contrast agents or media help physicians diagnose medical conditions by improving the vision. The material is absorbed by the body or eliminated through urine or bowel movements. 

Global contrast and imaging agents in interventional X-ray market is projected to register a healthy CAGR of 5.6% in the forecast period 2019 to 2026.

Segmentation: Interventional X-ray Market

Global contrast and imaging agents in interventional X-ray market is categorized into three segments which are agent type, application and end user.

On the basis of agent type, the market is segmented into iodinated contrast media, barium-based contrast media, microbubble contrast media, gold nanoparticle contrast agents and others. In 2019, iodinated contrast media segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.

In March 2017, GE Healthcare expanded its MRI contrast media product portfolio by launching a macrocyclic agent named Clariscan in Asia Pacific. This strategy helped the company to enhance its customer base and also expand their product portfolio.

On the basis of application, the market is segmented into cardiology, gastroenterology, neurology, oncology, urology and general Surgery. In 2019, cardiology segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.

Competitive Analysis: Interventional X-ray Market

Some of the major players operating in this market are

·         General Electric Company

·         Bracco

·         Lantheus Medical Imaging

·         Guerbet

·         FUJIFILM VisualSonics Inc

·         Jodas Expoim

·         TAEJOON PHARM

·         Unijules Life Sciences Ltd.

·         J.B.Chemicals & Pharmaceuticals Ltd.

·         iMAX

·         Novalek Pharmaceuticals Pvt. Ltd.

·        Nano Therapeutics Pvt Ltd

 Strategies:

In December2018, GE launched its e-learning portal at Lagos Garage Week 2018 in Nigeria. This would help thousands of Nigerians with advanced manufacturing training program.

In November 2018, GE and Dragos Industrial Controls Systems announced their collaboration. This would help the company to strengthen the industrial control systems.

In May 2018, Shanghai Pharmaceutical Group Co., Ltd. (China) and Bracco Imaging signed a collaboration agreement on the research and development activities in China. This strategy focused on the exploitation of the potentialities of Bracco Imaging microbubbles technology platform for supporting the development of new Shanghai Pharmaceuticals therapeutic products in the oncologic field.

 READ MORE

Contact:

Data Bridge Market Research

Email: Sales@databridgemarketresearch.com

Tel: +1-888-387-2818

[thevincyblr]

Global Contrast and Imaging Agents in Interventional X-ray Market – Industry Trends and Forecast to 2026

Contrast and imaging agents in interventional X-ray market plays an important role in improving the health-related issues in the healthcare sector. Contrast material, which is also known as contrast agents or contrast media, is used to improve image quality produced by X-rays, computed tomography (CT) and other imaging techniques. By using contrast materials radiologists can distinguish normal from abnormal conditions within the body.

Segmentation: Global Contrast and Imaging Agents in Interventional X-ray Market

Global contrast and imaging agents in interventional X-ray market is categorized into three segments which are agent type, application and end user.

·On the basis of agent type, the market is segmented into iodinated contrast media, barium-based contrast media, microbubble contrast media, gold nanoparticle contrast agents and others. In 2019, iodinated contrast media segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.

  In March 2017, GE Healthcare expanded its MRI contrast media product portfolio by launching a macrocyclic agent named Clariscan in Asia Pacific. This strategy helped the company to enhance its customer base and also expand their product portfolio.

Competitive Analysis: Global Contrast and Imaging Agents in Interventional X-ray Market

Some of the major players operating in this market are:-

1.      General Electric Company,

2.      Bracco, Lantheus Medical Imaging, Inc.,

3.      Guerbet,

4.      FUJIFILM VisualSonics Inc,

5.      Jodas Expoim,

6.      TAEJOON PHARM,

7.      Unijules Life Sciences Ltd.,

8.      J.B.Chemicals & Pharmaceuticals Ltd.,

9.      iMAX, 

10.   Novalek Pharmaceuticals Pvt. Ltd.,

11.   Nano Therapeutics Pvt Ltd

 READ MORE:

CONTACT US :

Customer Support 24*7

USA Number – +1 888 387 2818 (Toll – Free)

Europe Number – +44 208 089 1725

Asia Pacific Number – +81 34 520 8959

Skype.Address: databridgemarketresearch

Website : https://databridgemarketresearch.com

[databridgemarketresearch111-blog]

Global Contrast and Imaging Agents in Interventional X-ray Market – Industry Trends and Forecast to 2026

Contrast and imaging agents in interventional X-ray market plays an important role in improving the health-related issues in the healthcare sector. Contrast material, which is also known as contrast agents or contrast media, is used to improve image quality produced by X-rays, computed tomography (CT) and other imaging techniques. By using contrast materials radiologists can distinguish normal from abnormal conditions within the body.

Contrast agents or media doesn’t permanently discolour internal organs. Prior to the imaging exam, when the contrast agent is introduced in the body, these contrast materials forms some shape in the body which helps to appear different than that if no contrast agent is administered.

Segmentation: Global Contrast and Imaging Agents in Interventional X-ray Market

Global contrast and imaging agents in interventional X-ray market is categorized into three segments which are agent type, application and end user.

On the basis of agent type, the market is segmented into iodinated contrast media, barium-based contrast media, microbubble contrast media, gold nanoparticle contrast agents and others. In 2019, iodinated contrast media segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.

In March 2017, GE Healthcare expanded its MRI contrast media product portfolio by launching a macrocyclic agent named Clariscan in Asia Pacific. This strategy helped the company to enhance its customer base and also expand their product portfolio.

READ MORE

Competitive Analysis: Global Contrast and Imaging Agents in Interventional X-ray Market

Some of the major players operating in this market are General Electric Company, Bracco, Lantheus Medical Imaging, Inc., Guerbet, FUJIFILM VisualSonics Inc, Jodas Expoim, TAEJOON PHARM, Unijules Life Sciences Ltd., J.B.Chemicals & Pharmaceuticals Ltd., iMAX,  Novalek Pharmaceuticals Pvt. Ltd., Nano Therapeutics Pvt Ltd and among others.

CONTACT US: Customer Support 24*7

USA Number – +1 888 387 2818 (Toll – Free)

Europe Number – +44 208 089 1725

Asia Pacific Number – +81 34 520 8959

Skype.Address: databridgemarketresearch

Website: https://databridgemarketresearch.com

[chemicalsmaterial]

North America Contrast and Imaging Agents in Interventional X-Ray Market Trend

North America Contrast and Imaging Agents in Interventional X-Ray Market will exhibit a CAGR of 6.3% for the forecast period of 2021-2028

North America Contrast and Imaging Agents in Interventional X-Ray Market Analysis and Insights:

Contrast and imaging agents in interventional x-ray basically improves the health-related issues. Contrast material, is also referred as contrast agents/media, it improves image quality produced by computed tomography (CT), x-rays and others, which help to distinguish abnormal conditions within the body.

The Reports released the latest competent intelligence market research report on the Interventional X-ray Contrast and Imaging Agents Market, The report aims to provide a thorough and accurate analysis of the Interventional X-ray Contrast and Imaging Agents market, taking into account market forecast, competitive intelligence, technical risks, innovations, and other pertinent data. Its meticulously prepared market intelligence enables market players to comprehend the most important trends in the market that affect their business.

The rapid increase in the prevalence of stroke and cardiovascular disorder is primary factor responsible for driving the growth of the contrast and imaging agents in interventional x-ray market. Additionally, the rising demand for minimally invasive procedures, revelation to reduced amount of radiation and high imaging quality and growing demand for minimally invasive diagnostic and surgical procedures as well as the growing prevalence and incidence of chronic diseases also heighten the overall growth of the market. However, the rising adoption of refurbished interventional x-ray systems are estimated to obstruct the market’s growth.

The technological advancements, rising favorable reimbursement policy towards interventional surgeries and growing awareness amongst patients and practitioner for interventional surgeries are expected to generate profitable opportunities for the market.

This contrast and imaging agents in interventional x-ray market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.

Get full Report: https://www.databridgemarketresearch.com/reports/north-america-contrast-and-imaging-agents-in-interventional-x-ray-market

Competitive Landscape & North America Contrast and Imaging Agents in Interventional X-Ray Market Share Analysis:

North America Contrast and Imaging Agents in Interventional X-Ray market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of North America Contrast and Imaging Agents in Interventional X-Ray market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

 Get sample report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-contrast-and-imaging-agents-in-interventional-x-ray-market

 North America Contrast and Imaging Agents in Interventional X-Ray Market Segmentation Size:

Agent Types

·        Iodinated Contrast Media

·        Barium-Based Contrast Media

·        Microbubble Contrast Media

·        Gold Nanoparticle Contrast Agents

·        Others

Application

·        Cardiology

·        Gastroenterology

·        Neurology

·        Oncology

·        Urology

·        General Surgery

End User

·        Imaging Centres

·        Hospital

·        Clinics

·        Diagnostic Center

·        Ambulatory Surgical Centres

·        Private Practice

 North America Contrast and Imaging Agents in Interventional X-Ray Market Country Level Analysis:

North America contrast and imaging agents in interventional x-ray market is analysed and market size insights and trends are provided by agent type, application and end user as referenced above.

The countries covered in the North America Contrast and Imaging Agents in Interventional X-Ray report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

 Major Players:

·        General Electric,

·        Bracco,

·        Ziehm Imaging GmbH,

·        Lantheus Medical Imaging, Inc.,

·        Hitachi Ltd,

·        Guerbet,

·        Siemens,

·        FUJIFILM VisualSonics Inc,

·        Jodas Expoim,

·        Technix S.p.a.,

·        Hologic Inc,

·        Medtronic

  Major TOC of the Report:

Chapter One: Introduction

Chapter Two: Market Segmentation

Chapter Three: Market Overview  

Chapter Four: Executive Summary

Chapter Five: Premium Insight

Chapter Six: COVID-19 Impact on North America Contrast and Imaging Agents in Interventional X-Ray Market

 Get TOC here: https://www.databridgemarketresearch.com/toc/?dbmr=north-america-contrast-and-imaging-agents-in-interventional-x-ray-market

 About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

 Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[techsciresearch]

Contrast Media Injectors Market to grow at an Impressive CAGR During the Forecast Period | TechSci Research

Global Contrast Media Injectors Market is anticipated to grow on the backbone of technological advancements in the medical devices.

According to TechSci Research report, “Global Contrast Media Injectors Market By Product (Injector Systems v/s Consumables) By Injector Type (Single-head, Dual-head, Syringeless) By Application (Radiology, Interventional Cardiology, Others) By End User (Hospitals & Clinics, Ambulatory Care Centers, Diagnostic Centers) By Region, Competition Forecast & Opportunities, 2026”, the global contrast media injectors market is anticipated to grow in the forecast period from 2022 to 2026. Facts like IT enabled solutions for syringeless, dual-head, and automated injectors are expected to drive the market growth with an impressive CAGR in upcoming five years. Syringeless injectors are easier to use, and quite efficient. It allows to avoid the contrast agent wastage that may arise otherwise, also it provides contrast enhancement during imaging. Diagnostics require contrast media injectors to enhance blood and perfusion in tissues, and other processes to identify the issues. These processes were earlier carried out through invasive surgeries. Increased preference by patients for non-invasive, or minimally invasive procedures is driving the growth of global contrast media injectors market in next five years.

Moreover, surge in demand for non-invasive and minimally invasive surgery procedures is driving the growth of global contrast media injectors market in the forecast period. The process provides various perks over the main-line surgery procedures like, smaller incisions, rapid wound healing, shorter hospital stays, less pain, and minor surgical wounds. Procedures conducted with the contrast media injectors provide high quality, and real time imaging for the diagnostic or surgical procedures that creates a convenient opportunity for the surgeons allowing them to perform the surgery at the appropriate area. This factor is one of the major factors that is actively driving the global contrast media injector market growth in next five years.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Contrast media injectors Market"

https://www.techsciresearch.com/report/contrast-media-injectors-market/7366.html

The global contrast media injectors market is segmented on the basis of product, injector type, application, end user, regional distribution, and competitional landscape. Based on the injector type, the market is further categorized into single-head, dual-head, and syringeless. Single-head injector segment is anticipated to assert its dominance over the market in the forecast years. The wide range of usage of single-head injector as in angiography, CT, and MRI, drives the growth of the market segment. Moreover, single-head injectors are more cost effective than its competitor injector systems.

Thus, these products are more preferred in the developing nations like India, China, and Brazil.

Based on end user, the market is bifurcated into hospitals & clinics, ambulatory care centers, and diagnostic centers. Hospitals and clinics hold the largest market share and is expected to dominate the market segment owing to the increasing number of patients being admitted for the target diseases like cancer, cardiovascular disorders, and neurological disorders. Radiology department in the hospitals have the wide range of applications of contrast media injectors thereby driving the growth of the market segment. With the number of patients turnaround and readmissions in the hospitals the segment can well versed be said that it is anticipated to dominate the market in upcoming five years.

Some of the major competitors in the market are Bracco Imaging S.P.A, Bayer A.G., Guerbet Group, Ulrich GmbH & Co. KG, Nemoto Kyorindo Co., Ltd, Sino Medical-Device Technology Co., Ltd. (Sinomdt), APOLLO RT Co. Ltd., Shenzhen Anke High-tech Co. Ltd, Shenzen Seacrown Electromechanical Co Ltd., Medtron AG, among others. With technical advancements in the contrast media injectors, the market is anticipated to grow. Top players with their elaborative research and development of more efficient devices would drive the growth of the market. These activities along with partnerships and alliances would benefit the competitors to stabilize their market share.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7366

Customers can also request for 10% free customization on this report.

“Radiology involves the maximum application of the contrast media injectors for the early and feasible detection of carcinogenic cells, cardiovascular diseases, heart conditions, breast cancer, broken bones, gastrointestinal conditions, and blood clots in the veins. The life threatening diseases often involves elaborative and prolonged surgeries, if diagnostics and other surgical procedures can be conducted in a non-invasive or minimally invasive process, it is a beneficial factor for the patient and eradicates the chances of post-surgery complications. North American region may dominate the market owing to its excellent healthcare facility although European region with several major players of the market would have significant revenue share too,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global Contrast Media Injectors Market By Product (Injector Systems v/s Consumables) By Injector Type (Single-head, Dual-head, Syringeless) By Application (Radiology, Interventional Cardiology, Others) By End User (Hospitals & Clinics, Ambulatory Care Centers, Diagnostic Centers) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of Global Contrast media injectors and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Contrast media injectors.

Browse Related Reports:

Global Diagnostic Imaging Market By Product Type ( Architecture (Open/Closed), By Field Strength (High and Very-High Field MRI Systems), By Systems (Ultrasound Systems, Nuclear Imaging Systems, X-Ray Imaging Systems, CT Scanner, MRI System, Mammography System, Fluoroscopy), By Portability (Stationary, Portability), By Application (OB/Gyn, Orthopaedic, Musculosekeletal, Neuro &Spine, General Imaging, Cardio & Thoracic, Breast health, Others), By End Users (Hospitals, Diagnostic Imaging Centers, Others), By Region, Forecast & Opportunities, 2016-2026F

https://www.techsciresearch.com/report/diagnostic-imaging-market/4634.html

Global Bleeding Disorders Drugs Market By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others), By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By Gender (Male v/s Female), By End User (Hospitals, Hemophilia Treatment Centers, Research Institutes, Others), By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/bleeding-disorders-drugs-market/7331.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

[techscimarketresearch]

Contrast Media Injectors Market to grow at an Impressive CAGR During the Forecast Period | TechSci Research

Global Contrast Media Injectors Market is anticipated to grow on the backbone of technological advancements in the medical devices.

According to TechSci Research report, “Global Contrast Media Injectors Market By Product (Injector Systems v/s Consumables) By Injector Type (Single-head, Dual-head, Syringeless) By Application (Radiology, Interventional Cardiology, Others) By End User (Hospitals & Clinics, Ambulatory Care Centers, Diagnostic Centers) By Region, Competition Forecast & Opportunities, 2026”, the global contrast media injectors market is anticipated to grow in the forecast period from 2022 to 2026. Facts like IT enabled solutions for syringeless, dual-head, and automated injectors are expected to drive the market growth with an impressive CAGR in upcoming five years. Syringeless injectors are easier to use, and quite efficient. It allows to avoid the contrast agent wastage that may arise otherwise, also it provides contrast enhancement during imaging.  Diagnostics require contrast media injectors to enhance blood and perfusion in tissues, and other processes to identify the issues. These processes were earlier carried out through invasive surgeries. Increased preference by patients for non-invasive, or minimally invasive procedures is driving the growth of global contrast media injectors market in next five years.

Moreover, surge in demand for non-invasive and minimally invasive surgery procedures is driving the growth of global contrast media injectors market in the forecast period. The process provides various perks over the main-line surgery procedures like, smaller incisions, rapid wound healing, shorter hospital stays, less pain, and minor surgical wounds. Procedures conducted with the contrast media injectors provide high quality, and real time imaging for the diagnostic or surgical procedures that creates a convenient opportunity for the surgeons allowing them to perform the surgery at the appropriate area. This factor is one of the major factors that is actively driving the global contrast media injector market growth in next five years.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Contrast media injectors Market"

https://www.techsciresearch.com/report/contrast-media-injectors-market/7366.html

The global contrast media injectors market is segmented on the basis of product, injector type, application, end user, regional distribution, and competitional landscape. Based on the injector type, the market is further categorized into single-head, dual-head, and syringeless. Single-head injector segment is anticipated to assert its dominance over the market in the forecast years. The wide range of usage of single-head injector as in angiography, CT, and MRI, drives the growth of the market segment. Moreover, single-head injectors are more cost effective than its competitor injector systems.

Thus, these products are more preferred in the developing nations like India, China, and Brazil.

Based on end user, the market is bifurcated into hospitals & clinics, ambulatory care centers, and diagnostic centers. Hospitals and clinics hold the largest market share and is expected to dominate the market segment owing to the increasing number of patients being admitted for the target diseases like cancer, cardiovascular disorders, and neurological disorders. Radiology department in the hospitals have the wide range of applications of contrast media injectors thereby driving the growth of the market segment. With the number of patients turnaround and readmissions in the hospitals the segment can well versed be said that it is anticipated to dominate the market in upcoming five years.

Some of the major competitors in the market are Bracco Imaging S.P.A, Bayer A.G., Guerbet Group, Ulrich GmbH & Co. KG, Nemoto Kyorindo Co., Ltd, Sino Medical-Device Technology Co., Ltd. (Sinomdt), APOLLO RT Co. Ltd., Shenzhen Anke High-tech Co. Ltd, Shenzen Seacrown Electromechanical Co Ltd., Medtron AG, among others. With technical advancements in the contrast media injectors, the market is anticipated to grow. Top players with their elaborative research and development of more efficient devices would drive the growth of the market. These activities along with partnerships and alliances would benefit the competitors to stabilize their market share.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7366

Customers can also request for 10% free customization on this report.

“Radiology involves the maximum application of the contrast media injectors for the early and feasible detection of carcinogenic cells, cardiovascular diseases, heart conditions, breast cancer, broken bones, gastrointestinal conditions, and blood clots in the veins. The life threatening diseases often involves elaborative and prolonged surgeries, if diagnostics and other surgical procedures can be conducted in a non-invasive or minimally invasive process, it is a beneficial factor for the patient and eradicates the chances of post-surgery complications. North American region may dominate the market owing to its excellent healthcare facility although European region with several major players of the market would have significant revenue share too,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global Contrast Media Injectors Market By Product (Injector Systems v/s Consumables) By Injector Type (Single-head, Dual-head, Syringeless) By Application (Radiology, Interventional Cardiology, Others) By End User (Hospitals & Clinics, Ambulatory Care Centers, Diagnostic Centers) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of Global Contrast media injectors and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Contrast media injectors.

Browse Related Reports:

Global Diagnostic Imaging Market By Product Type ( Architecture (Open/Closed), By Field Strength (High and Very-High Field MRI Systems), By Systems (Ultrasound Systems, Nuclear Imaging Systems, X-Ray Imaging Systems, CT Scanner, MRI System, Mammography System, Fluoroscopy), By Portability (Stationary, Portability), By Application (OB/Gyn, Orthopaedic, Musculosekeletal, Neuro &Spine, General Imaging, Cardio & Thoracic, Breast health, Others), By End Users (Hospitals, Diagnostic Imaging Centers, Others), By Region, Forecast & Opportunities, 2016-2026F

https://www.techsciresearch.com/report/diagnostic-imaging-market/4634.html

Global Bleeding Disorders Drugs Market By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others), By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By Gender (Male v/s Female), By End User (Hospitals, Hemophilia Treatment Centers, Research Institutes, Others), By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/bleeding-disorders-drugs-market/7331.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

[deshpandeisha]

Market Trends in Angiography Equipment: Growth Drivers and Challenges

The Angiography Equipment market is a growing industry that is witnessing increasing demand for its applications in the diagnosis and treatment of cardiovascular diseases. Angiography is a medical imaging technique that uses X-rays and contrast agents to visualize the blood vessels in the body. The equipment used for angiography includes X-ray machines, catheters, and contrast agents, which are used to produce detailed images of the blood vessels.

The global angiography equipment market size is expected to reach USD 20.32 Billion in 2032, and register a revenue CAGR of 5.0% during the forecast period, according to latest analysis by Emergen Research. One of the major drivers of the Angiography Equipment market is the increasing prevalence of cardiovascular diseases. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, with an estimated 17.9 million deaths each year. As a result, there is a growing demand for medical devices and equipment, including angiography equipment, to diagnose and treat these diseases.

Another driver of the Angiography Equipment market is the technological advancements in the equipment. The development of digital angiography systems has improved the accuracy and efficiency of the diagnosis and treatment of cardiovascular diseases. Furthermore, the use of minimally invasive procedures, such as percutaneous coronary intervention (PCI), has increased the demand for angiography equipment, as it allows for safer and more precise procedures.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/1892

Competitive Terrain:

The global Angiography Equipment industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

GE HealthCare, Siemens, Koninklijke Philips N.V., Shimadzu Corporation, Terumo Corporation, Abbott, Boston Scientific Corporation, Medtronic, CANON MEDICAL SYSTEMS USA, INC., Cordis

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Angiography Equipment market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Angiography Equipment market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Angiography Equipment market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/1892

Market Segmentations of the Angiography Equipment Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Angiography Equipment market on the basis of product, application, and region:

Segments Covered in this report are:

Product Outlook (Revenue, USD Billion; 2019–2032)

Angiography Systems

Angiography Catheters

Angiography Contrast Media

Vascular Closure Devices (VCDs)

Angiography Balloons

Angiography Guidewires

Angiography Accessories

Technology Outlook (Revenue, USD Billion; 2019–2032)

X-Ray Angiography

Image Intensifiers

Flat-panel Detectors

CT Angiography

MR Angiography

Others

Procedure Outlook (Revenue, USD Billion; 2019–2032)

Coronary Angiography

Endovascular Angiography

Neuroangiography

Onco-Angiography

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/angiography-equipment-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1892

[kiransharma123]

Global Contrast and Imaging Agents in Interventional X-ray Market – Industry Trends and Forecast to 2026

Contrast and imaging agents in Interventional X-ray Market plays an important role in improving the health-related issues in the healthcare sector. Contrast material, which is also known as contrast agents or contrast media, is used to improve image quality produced by X-rays, computed tomography (CT) and other imaging techniques. By using contrast materials radiologists can distinguish normal from abnormal conditions within the body.

Contrast agents or media doesn’t permanently discolour internal organs. Prior to the imaging exam, when the contrast agent is introduced in the body, these contrast materials forms some shape in the body which helps to appear different than that if no contrast agent is administered. Contrast agents or media help physicians diagnose medical conditions by improving the vision. The material is absorbed by the body or eliminated through urine or bowel movements. 

Global contrast and imaging agents in interventional X-ray market is projected to register a healthy CAGR of 5.6% in the forecast period 2019 to 2026.

Competitive Analysis: Interventional X-ray Market

Some of the major players operating in this market are

·         General Electric Company

·         Bracco

·         Lantheus Medical Imaging

·         Guerbet

·         FUJIFILM VisualSonics Inc

·         Jodas Expoim

·         TAEJOON PHARM

·         Unijules Life Sciences Ltd.

·         J.B.Chemicals & Pharmaceuticals Ltd.

·         iMAX

·        Novalek Pharmaceuticals Pvt. Ltd.

·        Nano Therapeutics Pvt Ltd

Segmentation: Interventional X-ray Market

Global contrast and imaging agents in interventional X-ray market is categorized into three segments which are agent type, application and end user.

On the basis of agent type, the market is segmented into iodinated contrast media, barium-based contrast media, microbubble contrast media, gold nanoparticle contrast agents and others. In 2019, iodinated contrast media segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.

In March 2017, GE Healthcare expanded its MRI contrast media product portfolio by launching a macrocyclic agent named Clariscan in Asia Pacific. This strategy helped the company to enhance its customer base and also expand their product portfolio.

On the basis of application, the market is segmented into cardiology, gastroenterology, neurology, oncology, urology and general Surgery. In 2019, cardiology segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.

Strategies:

In December 2018, GE launched its e-learning portal at Lagos Garage Week 2018 in Nigeria. This would help thousands of Nigerians with advanced manufacturing training program.

In November 2018, GE and Drags Industrial Controls Systems announced their collaboration. This would help the company to strengthen the industrial control systems.

In May 2018, Shanghai Pharmaceutical Group Co., Ltd. (China) and Bracco Imaging signed a collaboration agreement on the research and development activities in China. This strategy focused on the exploitation of the potentialities of Bracco Imaging micro bubbles technology platform for supporting the development of new Shanghai Pharmaceuticals therapeutic products in the onco logic field.

READ MORE

Contact:

Data Bridge Market Research

Email: Sales@databridgemarketresearch.com

Tel: +1-888-387-2818

[thevincyblr]

Global Contrast and Imaging Agents in Interventional X-ray Market – Industry Trends and Forecast to 2026

Contrast and imaging agents in interventional X-ray market plays an important role in improving the health-related issues in the healthcare sector. Contrast material, which is also known as contrast agents or contrast media, is used to improve image quality produced by X-rays, computed tomography (CT) and other imaging techniques. By using contrast materials radiologists can distinguish normal from abnormal conditions within the body.

Read more:https://databridgemarketresearch.com/reports/global-contrast-and-imaging-agents-in-interventional-x-ray-market/

Contrast agents or media doesn’t permanently discolour internal organs. Prior to the imaging exam, when the contrast agent is introduced in the body, these contrast materials forms some shape in the body which helps to appear different than that if no contrast agent is administered. Contrast agents or media help physicians diagnose medical conditions by improving the vision. The material is absorbed by the body or eliminated through urine or bowel movements. There are various ways to use contrast material such as swallowed (taken by mouth or orally), injected into a blood vessel (vein or artery; also called given intravenously or intra-arterially) and administered by enema (given rectally). Different types of contrast materials are available including Iodine-based and barium-sulphate compounds used majorly in X ray and CT, Gadolinium which is used in magnetic resonance (MR) imaging and many others.Global contrast and imaging agents in interventional X-ray market is projected to register a healthy CAGR of 5.6% in the forecast period 2019 to 2026. Read More: https://databridgemarketresearch.com/reports/global-contrast-and-imaging-agents-in-interventional-x-ray-market/Segmentation:

 Global Contrast and Imaging Agents in Interventional X-ray MarketGlobal contrast and imaging agents in interventional X-ray market is categorized into three segments which are agent type, application and end user.On the basis of agent type, the market is segmented into iodinated contrast media, barium-based contrast media, microbubble contrast media, gold nanoparticle contrast agents and others. In 2019, iodinated contrast media segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.In March 2017, GE Healthcare expanded its MRI contrast media product portfolio by launching a macrocyclic agent named Clariscan in Asia Pacific. This strategy helped the company to enhance its customer base and also expand their product portfolio.

click on the link to view details: https://databridgemarketresearch.com/reports/global-contrast-and-imaging-agents-in-interventional-x-ray-market/Competitive Analysis: 

Global Contrast and Imaging Agents in Interventional X-ray MarketSome of the major players operating in this market are General Electric Company, Bracco, Lantheus Medical Imaging, Inc., Guerbet, FUJIFILM VisualSonics Inc, Jodas Expoim, TAEJOON PHARM, Unijules Life Sciences Ltd., J.B.Chemicals & Pharmaceuticals Ltd., iMAX,  Novalek Pharmaceuticals Pvt. Ltd., Nano Therapeutics Pvt Ltd and among others.

Contact: Customer Support 24*7USA Number – +1 888 387 2818 (Toll – Free)Europe Number – +44 208 089 1725Asia Pacific Number – +81 34 520 8959Skype.Address: databridgemarketresearch

[marketnewsreport]

Angiography Equipment Market Set to Grow at Healthy CAGR of 5.9% by 2025

Angiography Equipment Market is expected to reach USD 15.45 billion by 2025, from USD 13.06 billion in 2017 growing at a CAGR of 5.9% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2016 the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Major Market Competitors/Players: Global Angiography Equipment Market

Some of the major players operating in the market are GE Healthcare, Siemens, Royal Philips Electronics, Shimadzu Corporation, Terumo, Toshiba Medical Systems Corporation, Abbott Vascular (Abbott Laboratories), Boston Scientific, Medtronic, Providian Medical, Soma Technology, Inc., Canon Medical Systems, Medtronic, Inc., Cordis Corporation, B. Braun and  Angiodynamics among others.

Get Exclusive Sample Report: @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-angiography-equipment-market

Angiography is also known as arteriography. It is a medical imaging method used to envision the inside, or lumen of blood vessels and organs of the body, with particular interest in the arteries, veins and the heart chambers. This is usually performed by injecting a radio-opaque contrast agent into the blood vessel and imaging using X-ray based techniques such as fluoroscopy. In other word the angiography can also be defined as the test where dyes are seen by X-Rays injected into blood vessels that can be either arteries or veins and inspected using X-Rays. The subsequent images that are obtained are known as angiograms. Angiograms are used to identify narrowing or blockages in vessels anywhere in the body, from head to toe.

Competitive Analysis: Global Angiography Equipment Market

The global angiography equipment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Angiography Equipment market for global, Europe, North America, Asia Pacific and South America.

Inquiry Before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-angiography-equipment-market

Market Segmentation: Global Angiography Equipment Market

The global angiography equipment market is segmented based on product, technology, procedure, indication, application, end user and geographical segments.

·         Based on product, the market is segmented into angiography equipment solutions. The angiography equipment solutions segment is further sub-segmented into angiography systems, angiography catheters, angiography contrast media, vascular closure devices (VCDS), angiography balloons, angiography guidewires and angiography accessories.

·         On the basis of technology, the market is classified into X-Ray angiography, CT angiography, MR angiography and other angiography technologies. The X-Ray angiography is further classified into image intensifiers and flat-panel detectors.

·         On the basis of procedure, the market is segmented into coronary angiography, endovascular angiography, neuroangiography, onco-angiography and other angiography procedures.

·         Based on indication, the market is segmented into coronary artery disease, valvular heart disease, congenital heart disease, congestive heart failure and other indications.

·         Based on application, the market is segmented into diagnostics and therapeutics.

·         On the basis of procedure, the market is segmented into hospitals and clinics, diagnostic and imaging centers and research institutes.

·         Based on geography the global Angiography Equipment market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

Major Market Drivers and Restraints:

·         Growth in aging population and incidence of CVD

·         Growing awareness programs, conferences, and funding activities

·         Growing demand for interventional angiography systems in minimally invasive surgeries

·         Limitations in reimbursement for angiography procedures

·         Risk of radiation exposure

Get Detailed Toc and Charts & Tables @ https://databridgemarketresearch.com/toc/?dbmr=global-angiography-equipment-market          

Reasons to Purchase this Report

·         Current and future of global angiography equipment market outlook in the developed and emerging markets

·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

·         Regions/countries that are expected to witness the fastest growth rates during the forecast period

·         The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report

·         The report includes the complete segmentation displayed above across all above mentioned countries

·         All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[anitakumarigrewal]

According to the report analysis, ‘Canada Contrast and Imaging Agents in Interventional X-ray Market Industry Trends and Forecast to 2026’ states that the Canada contrast and imaging agents in Interventional X-ray Market is predicted to account a healthy a CAGR of 4.9% in the forecast period of 2019 to 2026. Whereas, contrast agents which are also known as contrast material or contrast media and effectively utilized to enhance the image quality introduced by the X-rays, computed tomography (CT) and other imaging manners. By utilizing the contrast materials radiologists can distinguish normal from abnormal conditions within the body. Not only has this, the contrast and imaging agents in the interventional X-rays market plays an efficient role in developing the health-related issues in the healthcare sectors.

Additionally, the players of this market are efficiently working in this market for leading the fastest market growth and dominating the handsome value of market share across the region while decreasing the side effects linked with the contrast agents and investing the high amount of money in the research and development programs including General Electric Company, BRACCO, Guerbet, Lantheus Medical Imaging, Inc., FUJIFILM VisualSonics Inc. and several others.

Moreover, such companies object for the sophisticated share through the indication extension strategies and policies in the foremost economies like U.S. With the sanctions for specific indications, companies object the niche patient cohorts and boom up the product adoption levels. However, the Guerbet, since it took over Mallinckrodt’s produces, is better positioned in the market. With the Dotarem under its meadow, Guerbet is now perplexing the Bayer’s Gadavist/Gadovist sales. This is one of the strategies utilized by the companies to augment their market share.

To one side from the competitive strategies, the fundamental influence associating this market is diagnostic process the volumes, stemming from the augmenting burden of the chronic diseases.

However, the market of contrast and imaging agents in the international X-rays in Canada is sectored into different sectors which majorly involves agent type, application and end user. Whereas, based on the agent type the market is further split into Iodinated Contrast Media, Barium-Based Contrast Media, Microbubble Contrast Media, Gold Nanoparticle Contrast Agents, several others while, the iodinated contrast media are registering as well as the fastest increasing sector in the Canada contrast and imaging agents in interventional X-ray market.

Yet, the sector of application includes Cardiology, Gastroenterology, Neurology, Oncology, Urology, General Surgery and for instance, the cardiology is accounting as well as the fastest augmenting segment in the Canada contrast and imaging agents in interventional X-ray market.

Although, the superior applicability of imaging modalities and convenience to recently-launched products for diagnosis of cancer and neurological and cardiovascular diseases support overall revenue growth. On the other hand, the nephrological, musculoskeletal, and neurological disorders sectors are predicted to witness moderate growth. Therefore, in the near future, it is anticipated that the market of contrast and imaging agents in the interventional X-Ray will increase across the Canada region more positively over the coming years.

To know more, click on the link below:-

Canada Contrast and Imaging Agents in Interventional X-ray Market

Related Reports:-

Global Contrast and Imaging Agents in Interventional X-ray Market Industry Trends Forecast to 2026

Middle East and Africa Contrast and Imaging Agents in Interventional X-ray Market Industry Trends Forecast to 2026

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Sales@kenresearch.com

+91-9015378249

[marketresearchblog1-blog]

Global Contrast and Imaging Agents in Interventional X-ray Market Forecast to 2026 Insights Shared In Detailed Report

Contrast and imaging agents in interventional X-ray market plays an important role in improving the health-related issues in the healthcare sector. Contrast material, which is also known as contrast agents or contrast media, is used to improve image quality produced by X-rays, computed tomography (CT) and other imaging techniques. By using contrast materials radiologists can distinguish normal from abnormal conditions within the body.

Contrast agents or media doesn’t permanently discolour internal organs. Prior to the imaging exam, when the contrast agent is introduced in the body, these contrast materials forms some shape in the body which helps to appear different than that if no contrast agent is administered. Contrast agents or media help physicians diagnose medical conditions by improving the vision.

Global contrast and imaging agents in interventional X-ray market is projected to register a healthy CAGR of 5.6% in the forecast period 2019 to 2026.

Segmentation:  Interventional X-ray Market

Global contrast and imaging agents in interventional X-ray market is categorized into three segments which are agent type, application and end user.

On the basis of agent type, the market is segmented into iodinated contrast media, barium-based contrast media, microbubble contrast media, gold nanoparticle contrast agents and others. In 2019, iodinated contrast media segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.

On the basis of application, the market is segmented into cardiology, gastroenterology, neurology, oncology, urology and general Surgery. In 2019, cardiology segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.

In March 2017, GE Healthcare expanded its MRI contrast media product portfolio by launching a macrocyclic agent named Clariscan in Asia Pacific. This strategy helped the company to enhance its customer base and also expand their product portfolio.

Competitive Analysis: Interventional X-ray Market

Some of the major players operating in this market are General Electric Company, Bracco, Lantheus Medical Imaging, Inc., Guerbet, FUJIFILM VisualSonics Inc, Jodas Expoim, TAEJOON PHARM, Unijules Life Sciences Ltd., J.B.Chemicals & Pharmaceuticals Ltd., iMAX,  Novalek Pharmaceuticals Pvt. Ltd., Nano Therapeutics Pvt Ltd and among others.

Strategies:

In December 2018, GE launched its e-learning portal at Lagos Garage Week 2018 in Nigeria. This would help thousands of Nigerians with advanced manufacturing training program.

In November 2018, GE and Dragos Industrial Controls Systems announced their collaboration. This would help the company to strengthen the industrial control systems.

In May 2018, Shanghai Pharmaceutical Group Co., Ltd. (China) and Bracco Imaging signed a collaboration agreement on the research and development activities in China. This strategy focused on the exploitation of the potentialities of Bracco Imaging microbubbles technology platform for supporting the development of new Shanghai Pharmaceuticals therapeutic products in the oncologic field.

In October 2017, Bracco Imaging acquired SurgVision (Netherlands). This acquisition helped the company to expand its innovative field of fluorescence imaging-guided surgery.

READ MORE

Contact:

Data Bridge Market Research

Email: Sales@databridgemarketresearch.com

Tel: +1-888-387-2818

[healthcarereportskbv]

Global Contrast Injector Systems Market- KBV Research

Cutting-edge healthcare spaces are rapidly adopting contrast injector systems because the technology offers wide-ranging imagery through various advanced technologies. Contrast injector systems use contrast media to develop the visibility of complex body structures like body fluids, arteries, tissues, and veins. Diagnostic processes are conducted using a number of imaging procedures like computed tomography (CT), magnetic resonance imaging (MRI), or angiography.

Innovations in technology have helped with the development of reasonably priced and completely automated contrast injector methodologies. Automated contrast injectors assist radiologists and other healthcare practitioners in plummeting the chances of human error and making the technology possible for customized patient treatment.

Click Here For Free Insights

Injecting contrast media into the arteries of patients helps in visualization of several pathologies through X-ray, magnetic resonance, computed tomography, and several other medical imaging devices. Contrast delivery is highly effective and proficient by using advanced medical devices that can be programmed to deliver definite amounts of contrast agent at defined flow rates.

The growing geriatric population along with a rapid surge in chronic diseases and the mandate for minimal-invasive diagnosis are propelling the growth and development of contrast injector systems.

Furthermore, the proliferation of healthcare expenditure and the emergence of complex diseases in evolving economies are creating money-spinning opportunities for industry.

According to a recent report by KBV Research, one of the leading market research companies, the global contrast injector system market is anticipated to reach $1.04 billion by 2024, growing at a CAGR of 7.9% over their estimated period.

CT Injector Systems

CT Injection Systems are feature-enriched, dual syringe injection systems that enable clinicians to perform the most critical CT contrast exams like cardiac CT and Coronary CTA. These contrast exams are performed with advances like simultaneous saline and contrast delivery. These injector systems are used for reliable performance where real-time graphics are requisite and accuracy is essential. The offered systems are manufactured by reliable vendors with the adoption of fine quality components and superior quality-modern technology.

Angiography Injector Systems

Physicians have been using angiography injectors for injecting contrast media in the arterial system of patients with the help of a catheter to diagnose vascular disease. Since non-invasive modalities are briskly becoming a preference for diagnosis, angiography injectors are profoundly compulsory to perform live imaging during therapeutic interventions like angioplasty or placement of stents.

Contrast Injector Systems for Cardiology

Contrast media injectors are used in cardiac imaging to improve patient safety and enrich image quality. These devices are capable of controlling contrast dosage, recording the amount used, and speed up injections to keep in pace with faster-computed tomography (CT) scanners. They can also warn clinicians about potential hazards, including air embolisms or extravasations.

Trends & Developments

Recent advances with contrast media injector technology have been introduced into the market. These include cost-cutting by dropping contrast waste and automated data collection for the dose a patient that a patient is given. Automated contrast injector systems ensure accurate control of the amount of contrast used. It also makes sure that vendors have moved into the software/IT arena by presenting custom-made dosages for patients. Contrast injector systems offer new potentials for radiology departments that are planning to streamline and record their contrast media usage. Several vendors have now incorporated X-ray radiation dose for recording capabilities as well.

The major trend in contrast media injector systems is the one that is emerging throughout the entire healthcare ecosphere: achieving more with less or maximizing the utility of present-day technology. Vendors are emphasizing on systems that make optimum use of existing contrast systems. Data management systems are being introduced to the market for several injector systems. These arrange for data to measure workflow efficiencies, imaging optimization, and patient welfare.

Contact Us:-

244 Fifth Avenue, Suite 1407

New York, N.Y. 10001

United States (U.S)

Tel: +1 (646) 661-6066

[ken-research-market-research]

Landscape of the Canada Contrast and Imaging Agents in the Interventional X-Ray Market Outlook: Ken Research

Landscape of the Canada Contrast and Imaging Agents in the Interventional X-Ray Market Outlook: Ken Research

Buy Now

According to the report analysis, ‘Canada Contrast and Imaging Agents in Interventional X-ray Market Industry Trends and Forecast to 2026’ states that the Canada contrast and imaging agents in Interventional X-ray Market is predicted to account a healthy a CAGR of 4.9% in the forecast period of 2019 to 2026. Whereas, contrast agents which are also known as contrast material or contrast…

[kiransharma123]

Global Contrast and Imaging Agents in Interventional X-ray Market – Industry Trends to 2026

Contrast and imaging agents in Interventional X-ray Market plays an important role in improving the health-related issues in the healthcare sector. Contrast material, which is also known as contrast agents or contrast media, is used to improve image quality produced by X-rays, computed tomography (CT) and other imaging techniques. By using contrast materials radiologists can distinguish normal from abnormal conditions within the body.

Contrast agents or media doesn’t permanently discolour internal organs. Prior to the imaging exam, when the contrast agent is introduced in the body, these contrast materials forms some shape in the body which helps to appear different than that if no contrast agent is administered. Contrast agents or media help physicians diagnose medical conditions by improving the vision. The material is absorbed by the body or eliminated through urine or bowel movements. 

Global contrast and imaging agents in interventional X-ray market is projected to register a healthy CAGR of 5.6% in the forecast period 2019 to 2026.

 Segmentation: Interventional X-ray Market

Global contrast and imaging agents in interventional X-ray market is categorized into three segments which are agent type, application and end user.

·         On the basis of agent type, the market is segmented into iodinated contrast media, barium-based contrast media, microbubble contrast media, gold nanoparticle contrast agents and others. In 2019, iodinated contrast media segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.

o   In March 2017, GE Healthcare expanded its MRI contrast media product portfolio by launching a macrocyclic agent named Clariscan in Asia Pacific. This strategy helped the company to enhance its customer base and also expand their product portfolio.

·         On the basis of application, the market is segmented into cardiology, gastroenterology, neurology, oncology, urology and general Surgery. In 2019, cardiology segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.

Competitive Analysis: Interventional X-ray Market

Some of the major players operating in this market are General Electric Company, Bracco, Lantheus Medical Imaging, Inc., Guerbet, FUJIFILM VisualSonics Inc, Jodas Expoim, TAEJOON PHARM, Unijules Life Sciences Ltd., J.B.Chemicals & Pharmaceuticals Ltd., iMAX,  Novalek Pharmaceuticals Pvt. Ltd., Nano Therapeutics Pvt Ltd and among others.

Strategies:

·         In December2018, GE launched its e-learning portal at Lagos Garage Week 2018 in Nigeria. This would help thousands of Nigerians with advanced manufacturing training program.

·         In November 2018, GE and Dragos Industrial Controls Systems announced their collaboration. This would help the company to strengthen the industrial control systems.

·         In May 2018, Shanghai Pharmaceutical Group Co., Ltd. (China) and Bracco Imaging signed a collaboration agreement on the research and development activities in China. This strategy focused on the exploitation of the potentialities of Bracco Imaging microbubbles technology platform for supporting the development of new Shanghai Pharmaceuticals therapeutic products in the oncologic field.

READ MORE

Contact:

Data Bridge Market Research

Email: Sales@databridgemarketresearch.com

Tel: +1-888-387-2818